Drug · DIN 02511827 · Veterinary
LIBRELA
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since March 8, 2023; first marketed March 8, 2023.
- Drug Identification Number (DIN)
- 02511827
- Company (DIN owner)
- Zoetis Canada IncKirkland, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Subcutaneous
- Class
- Veterinary
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| BEDINVETMAB | 20 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 1, 2021: NOC 25120New Drug Submission (NDS)
Other DINs named LIBRELA
- DIN 02511797 · Marketed
- DIN 02511800 · Marketed
- DIN 02511819 · Marketed
- DIN 02511835 · Marketed